Resources
For the latest in discovery & development, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Pharma Data
In Conversation With Dr. Maya Natarajan, Neo4J
In the lead up to our 2022 Pharma Data & SmartLabs Congress taking place this September, we sat down with Maya Natarajan, Senior Director Knowledge Graphs at Neo4j. Being a key player within the field, Maya gave us insights into the pioneering work Neo4j is doing with knowledge graphs and the types of graph analytics that Neo4J provides.
Target Discovery
University of Minnesota Awarded $6.5m for Male Contraceptive Discovery Effort
The grant could open the door to new oral contraceptive medication for men and prevent unwanted pregnancy.
Automation
Pharmaceutical Automation and the Factories of the Future: How Will the Industry Look in 2030?
With every new technological innovation, the pharmaceutical industry moves closer to the broader introduction of automation in production lines. But what bumps in the road to progress need to be smoothed out when it comes to the standardisation of industry approaches?
Discussion Group Report - Mobile Robotics
This November, our PharmaTec Series discussion group focused on mobile robotics. We explored their current uses, challenges and potential.
Target Discovery
Accelerating Target Discovery with Genomic and CRISPR Techniques
Benedict Cross, Chief Technology Officer at PhoreMost, leads our Discussion Group on Target-Based Drug Discovery using Genomic and CRISPR techniques.
Alzheimer’s Drug Lecanemab Slows Cognitive Decline at Cost of Side-Effects, Shows Clinical Trial
Eisai and Biogen have shared the data from a phase III trial of their joint effort Alzheimer’s drug, lecanemab
Automation
Applied Mobile Technologies and Interfacing with Robotics Software: Developing Improved Approaches for Cleanrooms
With the automation of cleanrooms set to continue for the foreseeable future, considering best practice approaches for integrating mobile robotics in a pharma-compliant manner will be key for addressing the needs of the industry. This Insight article explores some of the potential obstacles to the adoption of mobile robotics and considers how they could be addressed.
Target Discovery
Accelerating Target Deconvolution for Therapeutic Antibody Candidates
Target deconvolution is crucial to the phenotypic discovery process. Jenny Mattsson of BioInvent International explains how using CRISPR/Cas9 screening is a more efficient target deconvolution approach.
Small Molecule Targets Toxic RNA Linked to ALS and Dementia
A UF Scripps Biomedical Research team have developed an RNA-targeting blood-brain penetrant small molecule to tackle genetic cases of ALS and dementia.
Pharma Data
Data Management Strategies of Tomorrow: Bridging the Gap Between Retired Data Systems and Digital Innovation
Key opinion leaders from AbbVie, Genentech, and the University of Southampton ask, “how and why must we change the way we work with data?”
Molecular Drug Design
mRNA Vaccine Development to Get a Quantum Boost
Moderna will partner with IBM to deploy next-generation technologies such as quantum computing to optimise mRNA medicines.
Top 3 Must-See Presentations: Discovery US 2022
Find out what you can't miss at Discovery US: In Person 2022...
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery